OBESE
发表于 2025-3-21 17:06:48
书目名称Nachhaltigkeit ermöglichen影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0660380<br><br> <br><br>书目名称Nachhaltigkeit ermöglichen影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0660380<br><br> <br><br>书目名称Nachhaltigkeit ermöglichen网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0660380<br><br> <br><br>书目名称Nachhaltigkeit ermöglichen网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0660380<br><br> <br><br>书目名称Nachhaltigkeit ermöglichen被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0660380<br><br> <br><br>书目名称Nachhaltigkeit ermöglichen被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0660380<br><br> <br><br>书目名称Nachhaltigkeit ermöglichen年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0660380<br><br> <br><br>书目名称Nachhaltigkeit ermöglichen年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0660380<br><br> <br><br>书目名称Nachhaltigkeit ermöglichen读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0660380<br><br> <br><br>书目名称Nachhaltigkeit ermöglichen读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0660380<br><br> <br><br>
STELL
发表于 2025-3-21 22:15:45
http://reply.papertrans.cn/67/6604/660380/660380_2.png
Urea508
发表于 2025-3-22 01:50:05
Sabrina Kraussped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection. The conse
清醒
发表于 2025-3-22 06:10:06
Julia Plugmann,Philipp Plugmannped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection. The conse
Lipohypertrophy
发表于 2025-3-22 10:08:03
Arno Lammertsped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection. The conse
circumvent
发表于 2025-3-22 14:51:03
http://reply.papertrans.cn/67/6604/660380/660380_6.png
OTHER
发表于 2025-3-22 19:22:36
Claus Wilke,Stephan Graffs have topped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection.
鸣叫
发表于 2025-3-23 00:30:43
http://reply.papertrans.cn/67/6604/660380/660380_8.png
Subdue
发表于 2025-3-23 05:01:45
http://reply.papertrans.cn/67/6604/660380/660380_9.png
策略
发表于 2025-3-23 07:08:47
Nadine Krüger,Benjamin Zierock,Andreas Stanita,Christoph Hahns have topped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection.